{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T21:07:16Z","timestamp":1784408836691,"version":"3.55.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,27]]},"DOI":"10.7759\/cureus.109756","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:28:16Z","timestamp":1779906496000},"source":"Crossref","is-referenced-by-count":1,"title":["Atypical Management of Type 2 Amiodarone-Induced Thyrotoxicosis Without Corticosteroids: A Case Report and Review of Therapeutic Challenges"],"prefix":"10.7759","author":[{"given":"Kanza","family":"Wasim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2009.07.001","article-title":"Amiodarone and thyroid","volume":"23","author":"Eskes SA","year":"2009","unstructured":"Eskes SA, Wiersinga WM. Amiodarone and thyroid. Best Pract Res Clin Endocrinol Metab. 2009, 23:735-51. 10.1016\/j.beem.2009.07.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6614-6-S2-A23","article-title":"Amiodarone and the thyroid dysfunction","volume":"6","author":"Jastrz\u0119bska H","year":"2013","unstructured":"Jastrz\u0119bska H. Amiodarone and the thyroid dysfunction. Thyroid Res. 2013, 6:A23. 10.1186\/1756-6614-6-S2-A23","journal-title":"Thyroid Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross DS","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, et al.. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016, 26:1343-421. 10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","author":"Bogazzi F","year":"2010","unstructured":"Bogazzi F, Bartalena L, Martino E. Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 2010, 95:2529-35. 10.1210\/jc.2010-0180","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14341\/probl13348","article-title":"Type 2 amiodarone-induced thyrotoxicosis: prevalence, time and predictors of development [Article in Russian]","volume":"70","author":"Ermolaeva AS","year":"2023","unstructured":"Ermolaeva AS, Fadeev VV. Type 2 amiodarone-induced thyrotoxicosis: prevalence, time and predictors of development [Article in Russian]. Probl Endokrinol (Mosk). 2023, 70:9-22. 10.14341\/probl13348","journal-title":"Probl Endokrinol (Mosk)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-238145","article-title":"Amiodarone-induced type 2 thyrotoxicosis","volume":"14","author":"Portelli D","year":"2021","unstructured":"Portelli D, Mifsud S, Abela A, Fava S. Amiodarone-induced type 2 thyrotoxicosis. BMJ Case Rep. 2021, 14:10.1136\/bcr-2020-238145","journal-title":"BMJ Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/er.2006-0043","article-title":"The clinical significance of subclinical thyroid dysfunction","volume":"29","author":"Biondi B","year":"2008","unstructured":"Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008, 29:76-131. 10.1210\/er.2006-0043","journal-title":"Endocr Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1998.8.1123","article-title":"Amiodarone-induced thyrotoxicosis associated with thyrotropin receptor antibody","volume":"8","author":"Sato K","year":"1998","unstructured":"Sato K, Yamazaki K, Kanaji Y, Ohnishi S, Kasanuki H, Demura H. Amiodarone-induced thyrotoxicosis associated with thyrotropin receptor antibody. Thyroid. 1998, 8:1123-6. 10.1089\/thy.1998.8.1123","journal-title":"Thyroid"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/488611-atypical-management-of-type-2-amiodarone-induced-thyrotoxicosis-without-corticosteroids-a-case-report-and-review-of-therapeutic-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:28:20Z","timestamp":1779906500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/488611-atypical-management-of-type-2-amiodarone-induced-thyrotoxicosis-without-corticosteroids-a-case-report-and-review-of-therapeutic-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.109756","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,27]]}}}